by Feba Sam | Jul 10, 2018 | Science |
At Perlara, we work to find therapeutics for rare genetic diseases. We develop and use immunoassays, phase contrast imaging, as well as enzymatic assays, in order to screen thousands of compounds and obtain hits from cell readouts to complement our model organism...
by Aras Rezvanian | May 23, 2018 | Science |
One of the rare genetic disorders that we at Perlara have been working on is Mucolipidosis type IV (MLIV) – one of the Mucolipidosis group of inherited lysosomal storage disorders. For background on MLIV, and to learn more about our work in optimizing a MLIV drug...
by Feba Sam | Oct 29, 2016 | Perlara science |
High throughput screening (HTS) is essential in the process of finding a potential drug candidate, and automation is key for a good screen both in terms of robustness and efficiency. I kept hearing about the Echo since the day I joined Perlara, but it was only until a...
